Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001104659-26-009767 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | RYTM | Lee Jennifer Kayden | EVP, Head of North America | F - Tax | $108.99 | -9,237 | 19.2K | -32% | -$1.01M |
| D | 2026-02-03 | 2026-02-01 | RYTM | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +22.6K | 28.5K | +386% | — |
| DM | 2026-02-03 | 2026-02-01 | RYTM | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $0.00 | -22.6K | 27.5K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | F | D | 9,237 | $108.99 | 19,233 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-01 | M | A | 22,612 | — | 28,470 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 5,500 | $0.00 | 11,000 | D | — · — to — | 5,500 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F5) The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. |
| 4 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 4,512 | $0.00 | 4,512 | D | — · — to — | 4,512 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. |
| 5 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 3,437 | $0.00 | 0 | D | — · — to — | 3,437 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 9,163 | $0.00 | 27,487 | D | — · — to — | 9,163 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F6) The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. |